|
|
 |
MeTa equity worshop
The Medicines Transparency Alliance (MeTA):
Towards an equity and poverty focus
4 - 5 October 2007, London
This meeting arises from the recognition that there is much relevant work on
different aspects of equity in access to medicines. MeTA would like to learn
from this work and facilitate sharing of experience and insights on these
issues, which are likely to be an important stream of work for MeTA's
research network. The aims of the meeting were to
- Bring together wealth of academic and practitioner expertise on equity in access to medicines
- Sharpen thinking on poverty and equity issues in access to medicines so that MeTA processes and activities deliver objective of improving poor and disadvantaged people’s access
Background DFID documents
Background documents from participants
- Non-governmental Action to Improve the Access of the Poor to Good Quality Low Cost Drugs, M Mackintosh et al, The Open University, 2005
- Effect of payments for health care on poverty estimates in 11 countries in Asia, van Doorslaer et al, Lancet 2006
- Catastrophic payments for health care in Asia, Van Doorslaer et al, 2006
- Results of feasibility study using World Health Survey data to measure medicines need, use and out-of-pocket expenditures in eight low and lower-middle income countries, WHO and Harvard Medical School, 2007
- Health and Millennium Development Goal 1: Reducing out-of-pocket expenditures to reduce income poverty - Evidence from India, EQUITAP Project, 2005
- People living with HIV leading the way toward universal access, The Collaborative Fund for HIV Treatment Preparedness
- The health journey: Understanding the dimensions of care and treatment for people with HIV, HIV Alliance, 2007
|
|